title: Emergence of long-term surviving patients with the introduction of Cetuximab in recurrent/metastatic disease of squamous cell carcinoma of head and neck.
authors.affiliation: Medical Oncology Department, Catalan Institute of Oncology, Universidad de Barcelona, Av. Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: jlinares@iconcologia.net.
authors.forename: Jenniffer
authors.initials: J
authors.lastname: Linares
authors.affiliation: Medical Oncology Department, Catalan Institute of Oncology, Universidad de Barcelona, Av. Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: arullan@iconcologia.net.
authors.forename: Antonio
authors.initials: A
authors.lastname: Rullan
authors.affiliation: Medical Oncology Department, Catalan Institute of Oncology, Universidad de Barcelona, Av. Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: mtaberna@iconcologia.net.
authors.forename: Miren
authors.initials: M
authors.lastname: Taberna
authors.affiliation: Medical Oncology Department, Catalan Institute of Oncology, Universidad de Barcelona, Av. Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: silviavazquez@iconcologia.net.
authors.forename: Silvia
authors.initials: S
authors.lastname: Vazquez
authors.affiliation: Medical Oncology Department, Catalan Institute of Oncology, Universidad de Barcelona, Av. Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: rmesia@iconcologia.net.
authors.forename: Ricard
authors.initials: R
authors.lastname: Mesia
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D000068818:Cetuximab / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000068818:Cetuximab